202 related articles for article (PubMed ID: 16094406)
1. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
Boos CJ; Lip GY
J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
[No Abstract] [Full Text] [Related]
2. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
3. [Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
Geller JC
MMW Fortschr Med; 2003 Nov; 145(47):38-41. PubMed ID: 14725032
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
Heusch G; Schulz R
Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
[TBL] [Abstract][Full Text] [Related]
5. [Dual blockade of the renin-angiotensin system].
Andersen NH; Mogensen CE
Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108
[No Abstract] [Full Text] [Related]
6. Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system.
Le Heuzey JY; Marijon E; Chachoua K; Waintraub X; Lepillier A; Otmani A; Lavergne T; Pornin M
Arch Cardiovasc Dis; 2008; 101(11-12):787-91. PubMed ID: 19059574
[TBL] [Abstract][Full Text] [Related]
7. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
Lau YF; Yiu KH; Siu CW; Tse HF
J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
Levine MJ; Schweitzer P
Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
[TBL] [Abstract][Full Text] [Related]
9. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
Dabrowski R; Szwed H
Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
[No Abstract] [Full Text] [Related]
10. Summaries for patients. Effect of antihypertensive drugs on risk for atrial fibrillation.
Ann Intern Med; 2010 Jan; 152(2):I-16. PubMed ID: 20083810
[No Abstract] [Full Text] [Related]
11. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
13. More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).
Lip GY; Beevers DG
J Hum Hypertens; 2003 Nov; 17(11):747-50. PubMed ID: 14578913
[No Abstract] [Full Text] [Related]
14. [Atrial fibrillation and renin-angiotensin system].
Yamashita T
Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
[TBL] [Abstract][Full Text] [Related]
15. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Kalus JS; Coleman CI; White CM
J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
17. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and atrial cardiomyopathy--two sides of the same coin?
Pedersen OD; Køber L; Torp-Pedersen C
Am Heart J; 2004 Jun; 147(6):953-5. PubMed ID: 15199340
[No Abstract] [Full Text] [Related]
19. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
Baker WL; White CM
Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
